ANTH - Anthera Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-1453,185-
Cost of Revenue28,49446,25130,86021,839
Gross Profit-28,494-46,106-27,675-21,839
Operating Expenses
Research Development----
Selling General and Administrative7,93811,0717,5686,620
Non Recurring----
Total Operating Expenses36,43257,32238,42828,459
Operating Income or Loss-36,432-57,177-35,243-28,459
Income from Continuing Operations
Total Other Income/Expenses Net9,5581,65423-1,145
Earnings Before Interest and Taxes-36,432-57,177-35,243-28,459
Interest Expense----1,049
Income Before Tax-26,874-55,523-35,220-29,604
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-26,874-55,523-35,220-29,604
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-26,874-55,523-35,220-29,604
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-29,377-66,437-35,220-29,604